Oncovir, Inc. Employee Directory
Pharmaceutical ManufacturingDistrict of Columbia, United States2-10 Employees
Oncovir, Inc. is a small pharmaceutical manufacturing company focused on developing nucleic-acid–based clinical therapies for cancer, infectious, immune, and degenerative disorders. Its lead product, Hiltonol® (poly-ICLC), is promoted as a viral mimic that broadly activates innate and adaptive immunity, with effects ranging from antiviral and immune-stimulating actions to vaccine adjuvant and antitumor activity. Based in Washington, DC, the firm operates within the pharmaceutical sector and targets applications that leverage immune-based approaches to disease, seeking to address unmet needs in oncology and related fields. The organization emphasizes experimental and clinical-stage development of immune-modulating therapies and remains centered in the national capital area, reflecting its comparatively small size and specialized focus.